Patents

BiBB’s IP portfolio is one of the company’s most important assets. All of BiBB’s products have either been granted a patent or have a patent pending. The patents are valid until at least 2033. In addition to the patents, the EndoDrill^® trademark has been registered in Europe. In 2018, the company’s existing patent portfolio were strengthened with new applications for EndoDrill^® Core Needle and EndoDrill^® Model X to ensure the best possible scope of protection.

The first patent family, “EndoDrill^®”, is a more general application for a biopsy instrument with drill bit, flexible introducer (wire) and handle. The patent has been granted in Europe, China and Australia, and is pending in the USA, India and Canada. Granted patents provide protection until August 2033.

The other patent family, “Handle”, relates to a patent application that describes the EndoDrill^® and the handle in particular in more detail. This application covers the EndoDrill^® instrument as a whole. The patent has been granted in China and Australia, and is pending in the USA, Europe, Japan, India and Canada. Granted patents provide protection until June 2035. 

In addition to the “EndoDrill” and “Handle” patent families, BiBB has filed patent applications for EndoDrill^® Core Needle and EndoDrill^® Model X. Granted patents provide the company protection for the instruments until 2038 and 2039, respectively. The table below lists the company’s granted patents, pending patents and the status of EndoDrill^® trademark registration:

Patent family	Patent application	Approved patent	Valid until
EndoDrill	USA, Canada, India, China, Australia, Europe (divisional application)	Europe, China, Australia	2033
Handle	Europe, USA, Canada, India, China, Japan	China, Australia	2035
EndoDrill Core Needle	Sweden, international application will be filed in 2019		2038
EndoDrill Core Needle (Design)	Europe, USA	Europe, China, Japan	2043
EndoDrill Model X	Europe, international application will be filed in 2019		2038